Motusol Max 12-Hour Pain Relief (Diclofenac Diethylamine)

Diclofenac Diethylamine, the active ingredient in Motusol Max 12-Hour Pain Relief, is a nonsteroidal anti-inflammatory drug (NSAID) presented as a topical formulation for cutaneous use. It treats mild to moderate musculoskeletal pain and reduces localized inflammation in adults.

GNH USA supplies Motusol Max 12-Hour Pain Relief as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Diclofenac Diethylamine is applied topically to manage pain and inflammation within the musculoskeletal system.

- Musculoskeletal pain: provides relief of mild to moderate pain in muscles and joints. - Sports injuries: reduces pain and swelling associated with strains and sprains. - Post‑traumatic sprains: alleviates discomfort and local inflammation. - Localized osteoarthritis: helps manage joint pain in affected areas. - Localized rheumatoid arthritis flare: reduces inflammation and tenderness at the site of application.

Topical diclofenac may cause local skin reactions, though most are mild and reversible.

Common Side Effects: - Skin irritation: mild redness or discomfort at the application site. - Erythema: localized redness of the skin. - Pruritus: itching where the gel is applied. - Burning sensation: transient warmth or stinging. - Dry skin: occasional dryness or flaking. - Contact dermatitis: mild allergic skin response.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Stevens‑Johnson syndrome: rare but serious skin disorder. - Toxic epidermal necrolysis: life‑threatening skin detachment. - Systemic NSAID toxicity: rare systemic effects if absorbed in large amounts. - Severe photosensitivity: heightened skin reaction to sunlight. - Ulceration: rare skin ulcer formation at the site.

When using topical diclofenac, consider the following safety measures.

- Pregnancy: avoid use unless the prescriber determines benefits outweigh risks. - Breastfeeding: consult a healthcare professional before application. - Concomitant anticoagulants: monitor for increased bleeding tendency. - Skin integrity: do not apply to broken, infected, or irritated skin. - NSAID allergy: contraindicated in patients with known hypersensitivity to diclofenac or other NSAIDs. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Topical diclofenac can interact with systemic medications; awareness of these interactions helps minimise risk.

Major Interactions (Avoid): - Oral anticoagulants: may increase bleeding risk. - Systemic NSAIDs: additive toxicity and gastrointestinal risk. - Lithium: potential for increased lithium serum levels.

Moderate Interactions (Monitor Closely): - ACE inhibitors: possible alteration of renal function. - Diuretics: heightened risk of renal impairment. - Methotrexate: enhanced toxicity when combined with NSAIDs.